Gen Z’s expensive drug habit: More want brand-name meds that are 79% more expensive
© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use ...
© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use ...
That is the subtitle of a paper by Vreman et al. (2020). The authors look ...
CAMBRIDGE, MA—Jeffrey W. Albers, a director at Blueprint Medicines Corp (NASDAQ:), recently executed a significant stock transaction, according to a ...
© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use ...
Dyne Therapeutics started the new year with proof-of-concept clinical data for experimental genetic medicines addressing two rare muscle diseases—one of ...
Copyright © 2024 EuroAsia24 News.
EuroAsia24 News is not responsible for the content of external sites.